Dr. Hom studies various conditions primarily affecting children, particularly those with heart conditions and infections from bacteria like mycobacteria, which can cause diseases such as tuberculosis. She has implemented proactive strategies in pediatric cardiac care to significantly reduce cardiac arrest risks and improve safety in hospitals. Moreover, she designs standardized guidelines for managing newborns with heart defects diagnosed before birth, aiming to ensure these vulnerable patients receive the best possible care immediately after delivery. Her research also encompasses creating international standards for measuring health outcomes in patients with congenital heart disease, facilitating better treatments and care approaches.
Key findings
Achieved a 68% reduction in cardiac arrest cases in children with heart conditions over the course of a year.
Developed a widely agreed-upon framework that identifies 15 crucial health outcomes for patients with congenital heart disease, with over 80% support from experts and patients.
Established a specific care plan for newborns diagnosed with congenital heart disease, leading to improved stabilization of heart and breathing functions right after birth.
Identified that the Glis3 protein plays a key role in regulating the development of insulin-producing pancreatic cells, which can inform diabetes treatments.
Measured changes in the popliteal angle of 130 infants, finding significant relaxation in leg flexibility by eight months, aiding early detection of potential muscle issues.
Frequently asked questions
Does Dr. Hom study congenital heart disease?
Yes, Dr. Hom focuses extensively on congenital heart disease, working on improving healthcare outcomes for affected patients.
What treatments has Dr. Hom researched for cardiac conditions?
Dr. Hom has developed proactive strategies in pediatric cardiac care to reduce risks of cardiac arrest and improve newborn management for heart defects.
Is Dr. Hom's work relevant to patients with tuberculosis?
Yes, her research on mycobacteria helps improve understanding and treatment options for infections like tuberculosis.
How does Dr. Hom's work benefit newborns?
Her studies on management strategies for newborns with congenital heart disease aim to stabilize vital functions immediately after birth, enhancing their survival chances.
What health outcomes does Dr. Hom's research aim to measure?
She has established a framework that tracks important physical and mental health outcomes for patients with congenital heart disease.
Publications in plain English
Mechanical morphotype switching as an adaptive response in mycobacteria.
2024
Science advances
Eskandarian HA, Chen YX, Toniolo C, Belardinelli JM, Palcekova Z +6 more
Plain English This research looked at how certain bacteria called mycobacteria can change their structure to survive attacks from immune cells in the body. The scientists found that when these bacteria turned into a "softer" form, they were better able to survive inside immune cells, specifically during exposure to harmful substances like cathelicidin. This finding is important because it reveals a new way these bacteria adapt to survive in a host, which could lead to better treatments for infections caused by mycobacteria.
Who this helps: This helps patients with infections caused by mycobacteria, such as tuberculosis.
Shifting the Paradigm: A Quality Improvement Approach to Proactive Cardiac Arrest Reduction in the Pediatric Cardiac Intensive Care Unit.
2022
Pediatric quality & safety
Riley CM, Diddle JW, Harlow A, Klem K, Patregnani J +6 more
Plain English This study focused on reducing the risk of cardiac arrest in children with heart conditions in a specialized care unit. The researchers created a program that aimed to cut down cardiac arrest cases by half in one year. They achieved even better results, reducing cardiac arrest rates by 68% and preventing severe complications and deaths among patients.
Who this helps: This helps children with cardiac conditions and their families by improving safety in hospitals.
Standardized delivery room management for neonates with a prenatal diagnosis of congenital heart disease: A model for improving interdisciplinary delivery room care.
2021
Journal of neonatal-perinatal medicine
Sethi N, Klugman D, Said M, Hom L, Bowers S +3 more
Plain English The study focused on how to improve care for newborns with heart defects diagnosed before birth. Researchers found that having a specific care plan for these babies can help stabilize their heart and breathing right after they are born. This is important because timely and targeted care can significantly improve their chances of a better outcome.
Who this helps: This helps newborns with congenital heart disease and the healthcare teams caring for them.
Development of an international standard set of clinical and patient-reported outcomes for children and adults with congenital heart disease: a report from the International Consortium for Health Outcomes Measurement Congenital Heart Disease Working Group.
2021
European heart journal. Quality of care & clinical outcomes
Hummel K, Whittaker S, Sillett N, Basken A, Berghammer M +17 more
Plain English This study focused on creating a worldwide standard for measuring the health outcomes of children and adults with congenital heart disease (CHD). Researchers gathered input from CHD experts and patients to identify 15 important health outcomes, which include physical and mental health, that should be tracked. Over 80% of people surveyed agreed with these outcomes, making this the first widely supported framework for measuring how CHD impacts patients' lives and guiding healthcare improvements.
Who this helps: This benefits patients with congenital heart disease and the healthcare providers who treat them.
The impact of initiating rivaroxaban versus low-molecular weight heparin plus warfarin in patients admitted to the hospital for venous thromboembolism.
Glis3 regulates neurogenin 3 expression in pancreatic β-cells and interacts with its activator, Hnf6.
2012
Molecules and cells
Kim YS, Kang HS, Takeda Y, Hom L, Song HY +2 more
Plain English This study looked at how a protein called Glis3 affects the expression of a gene called Neurogenin 3 (Ngn3) in the cells of the pancreas that produce insulin. The researchers found that Glis3 can directly bind to the Ngn3 gene and help activate its expression, alongside another protein called Hnf6. This discovery is important because understanding how Glis3 and Hnf6 work together could lead to better treatments for diabetes, specifically by improving how insulin-producing cells develop.
Who this helps: This helps patients with diabetes, particularly those with neonatal diabetes.
Changes in popliteal angle measurement in infants up to one year of age.
1984
Developmental medicine and child neurology
Reade E, Hom L, Hallum A, Lopopolo R
Plain English This study looked at how the popliteal angle, which measures flexibility in babies' legs, changes in infants up to one year old. Researchers measured this angle in 130 healthy infants and found that the angle was tight at birth but relaxed considerably by eight months, with most infants showing no limitation by then. This matters because understanding these changes helps doctors identify potential muscle issues in infants early on.
Who this helps: This helps doctors and healthcare providers assess and treat infants with possible muscle problems.
Haig Alexander Eskandarian Yu-Xiang Chen Chiara Toniolo Juan M Belardinelli Zuzana Palcekova Paul D Ashby Georg E Fantner Mary Jackson John D McKinney Babak Javid
Physician data sourced from the
NPPES NPI Registry
.
Publication data from
PubMed
.
Plain-English summaries generated by AI.
Not medical advice.